Search

Author/Creator Patzke, Holger

1. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. Issue 1 (December 2016)

Authors:
Blain, Jean-François; Bursavich, Matthew; Freeman, Emily; Hrdlicka, Lori; Hodgdon, Hilliary; Chen, Ting; Costa, Don; Harrison, Bryce; Kapadnis, Sudarshan; Murphy, Deirdre; Nolan, Scott; Tu, Zhiming; Tang, Cuyue; Burnett, Duane; Patzke, Holger; Koenig, Gerhard
Journal:
Alzheimer's research & therapy
Issue:
Volume 8:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. O4‐02‐01: PHASE 2A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM‐0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS. (1st July 2019)

Authors:
Boxer, Adam L.; Moebius, Hans; Harris, Baruch; Boeve, Bradley F.; Borroni, Barbara; van Swieten, John C.; Grossman, Murray; Pasquier, Florence; Frisoni, Giovanni B.; Mummery, Catherine J.; Vandenberghe, Rik; Le Ber, Isabelle; Hannequin, Didier; McGinnis, Scott M.; Auriacombe, Sophie; Onofrj, Marc...
Journal:
Alzheimer's & dementia
Issue:
Volume 15:Supplement 7S(2019)Part 23
Page Start:
P1231
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗